POST THROMBOTIC SYNDROME
Clinical trials for POST THROMBOTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POST THROMBOTIC SYNDROME trials appear
Sign up with your email to follow new studies for POST THROMBOTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Statins may offer extra clot protection for blood clot patients
Disease control Recruiting nowThis study tests whether adding rosuvastatin (a cholesterol-lowering drug) to standard blood thinners can lower the risk of another blood clot in people who recently had a deep vein thrombosis or pulmonary embolism. About 2700 participants will receive either rosuvastatin or a pl…
Matched conditions: POST THROMBOTIC SYNDROME
Phase: PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
New device aims to zap DVT clots and prevent lasting leg damage
Disease control Recruiting nowThis study tests a device called ClotTriever that physically removes blood clots from the leg veins, compared to standard blood thinner medication alone. About 300 adults with recent, severe deep vein thrombosis (DVT) in one leg will be randomly assigned to one of the two treatme…
Matched conditions: POST THROMBOTIC SYNDROME
Phase: NA • Sponsor: Inari Medical • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC